Investor mix
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 1 | 50% |
| Other / undisclosed | 1 | 50% |
Taiwanese biotech company that develops cell-based human vaccines for H5N1 and Enterovirus 71
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 1 | 50% |
| Other / undisclosed | 1 | 50% |